abstract |
The present invention relates to a method of treating migraine in a mammal, including anhuman, by administering to the mammal a 5HT 1 receptor agonist in combination with either ancyclooxygenase-2 (COX-2) inhibitor or a nonsteroidal antiinflammatory drug (NSAID). It alsonrelates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a 5HT 1 nreceptor agonist with either a cyclooxygenase-2 (COX-2) inhibitor or a nonsteroidalnantiinflammatory drug (NSAID). |